Nivolumab plus ipilimumab, with or without enzalutamide, in AR‐V7‐expressing metastatic castration‐resistant prostate cancer: A phase‐2 nonrandomized clinical trial

Bibliographic Details
Title: Nivolumab plus ipilimumab, with or without enzalutamide, in AR‐V7‐expressing metastatic castration‐resistant prostate cancer: A phase‐2 nonrandomized clinical trial
Authors: Shenderov, Eugene, Boudadi, Karim, Fu, Wei, Wang, Hao, Sullivan, Rana, Jordan, Alice, Dowling, Donna, Harb, Rana, Schonhoft, Joseph, Jendrisak, Adam, Carducci, Michael A., Eisenberger, Mario A., Eshleman, James R., Luo, Jun, Drake, Charles G., Pardoll, Drew M., Antonarakis, Emmanuel S.
Source: Prostate. 81(6):326-338
Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100116967691.0x000001&indx=1&recIds=ETOCvdc_100116967691.0x000001
Database: British Library Document Supply Centre Inside Serials & Conference Proceedings
More Details
ISSN:02704137
Published in:Prostate
Language:English